 Guardant Health Inc NASDAQ: GH has decided not to pursue a potential acquisition of NeoGenomics Inc NASDAQ: NEO, Bloomberg reported citing people familiar with the matter. Related: Guardant Health Weighing NeoGenomics Acquisition: Bloomberg. 